Reply

Affiliations

Comment

Xiu-Ping Zhang et al. Hepatology. 2019 Nov.

. 2019 Nov;70(5):1878-1879.

doi: 10.1002/hep.30873.

¹ Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.

No abstract available

Comment on

An Eastern Hepatobiliary Surgery Hospital/Portal Vein Tumor Thrombus Scoring System as an Aid to Decision Making on Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: A Multicenter Study.
Zhang XP, Gao YZ, Chen ZH, Chen MS, Li LQ, Wen TF, Xu L, Wang K, Chai ZT, Guo WX, Shi J, Xie D, Wu MC, Yee Lau W, Cheng SQ. Zhang XP, et al. Hepatology. 2019 May;69(5):2076-2090. doi: 10.1002/hep.30490. Epub 2019 Mar 12. Hepatology. 2019. PMID: 30586158
Letter to the Editor: Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: Benefit or Not.
Luo F, Liao R. Luo F, et al. Hepatology. 2019 Nov;70(5):1877-1878. doi: 10.1002/hep.30872. Hepatology. 2019. PMID: 31343750 No abstract available.

1. Liu S, Guo L, Li H, Zhang B, Sun J, Zhou C, et al. Postoperative adjuvant trans-arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg Oncol 2018;25:2098-2104.
1. Zhang XP, Liu YC, Chen ZH, Sun JX, Wang K, Chai ZT, et al. Postoperative adjuvant transarterial chemoembolization improves outcomes of hepatocellular carcinoma associated with hepatic vein invasion: a propensity score matching analysis. Ann Surg Oncol 2019;26:1465-1473.